According to a report by Bloomberg, the U.S. Food and Drug Administration is reviewing epidural injections of steroids to treat neck and back pain.

This was after a warning by Bristol-Myers Squibb (NYSE:BMY) seven months ago that administering its Kenalog steroid around the spine could cause serious complications.

From Medcitynews.com:

Bristol-Myers in New York revised its label for Kenalog to say it is not recommended for injection into the epidural space near the spine because of “reports of serious medical events, including death,” associated with administering steroids that way, the article said. But the drugmaker and the FDA have not yet publicized the label change, Bloomberg said.

Bloomberg said Bristol-Myers’ steroid Kenalog and the Pfizer (NYSE:PFE) drug Depo-Medrol are the most commonly used steroids for epidural injections.

Posted in Steroids